Skip to content

Effect of Transcutaneous Acupoint Electrical Stimulation on Catheter-Related Bladder Discomfort After Transurethral Endoscopic Surgery

Effect of Transcutaneous Acupoint Electrical Stimulation on Catheter-related Bladder Stimulation Signs After Transurethral Endoscopic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121349
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-Related Bladder Discomfort

Interventions

TEAS group:30 minutes before surgery initiation, electrodes were applied to the CV4 (Guanyuan) and CV3 (Zhongji) acupoints. Transcutaneous electrical acupoint stimulation (TEAS) was delivered using a
a single continuous stimulation session did not exceed 6 hours, and was paused and resumed as necessary.
control group:30 minutes before surgery initiation, electrodes were applied to the same acupoints. An identical-appearing TEAS device was connected with the same frequency and pulse width parameters,

Sponsors

The First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Males aged 18~85 years old (based on the date of surgery); 2. American Society of Anesthesiologists (ASA) physical status class I-III; 3. Proposed elective general anesthesia descending transurethral bladder/prostate endoscopic surgery; 4. Indwelling urinary catheter is planned to be placed for >=24 hours after surgery, and continuous bladder irrigation is required; 5. Able to communicate effectively with the researcher and cooperate with the completion of relevant assessments and 14-day postoperative follow-up; 6. Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Allergic to study-related anesthetic drugs; 2. Severe liver, kidney, heart, lung, and brain diseases before surgery; 3. History of mental illness/substance abuse; 4. History of acute urinary retention, preoperative urinary tract infection or bladder perfusion chemotherapy; 5. Contraindications related to TEAS (pacemaker, metal implantation or allergy to epidermal electrodes, skin sensory disorders, skin breakdown, scarring, adhesions that have not healed); 6. Coagulation dysfunction; 7. Expected discharge within 24 hours after surgery.

Design outcomes

Primary

MeasureTime frame
Incidence of moderate to severe catheter-related bladder discomfort at 1 hour postoperatively;

Secondary

MeasureTime frame
Incidence of delirium during the recovery period;Use of salvage antispasmodic medications within 48 hours postoperatively;Pain scores at rest and during bladder irrigation at 1h, 6h, 48h, and 14 days postoperatively;Use of salvage analgesics and opioid consumption (expressed as morphine equivalents) within 48 hours postoperatively;Anxiety scores at 1h, 6h, 48h, and 14 days postoperatively;Nausea and vomiting scores at 1h, 6h, 48h, and 14 days postoperatively;Cognitive function scores at 1h, 6h, 48h, and 14 days postoperatively;Sleep quality scores at 48h and 14 days postoperatively;Quality of recovery score at 14 days postoperatively;Incidence and severity of CRBD at 6h and 48h postoperatively;Length of postoperative hospital stay;Incidence of complications at 14 days postoperatively;

Countries

China

Contacts

Public ContactYi Zhou

The First Affiliated Hospital of Naval Medical University

yizhoumz@163.com+86 137 6129 3168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026